News

Letter to customers--YIFAN BIOTECHNOLOGY GROUP resumes production under COVID-19 outbreak

Dear customers,

 

This is an extraordinary and memorable moment for all of us. The outbreak of COVID-19 has touched the hearts of every Chinese and overseas friends. During the virus spreading, please take protective measures to ensure your health.

 

YIFAN BIOTECHNOLOGY GROUP CO., LTD. has actively responded to relevant national policies and cooperated with the government in epidemic management. Hence the company has set up the "YIFAN epidemic prevention and control leading group", with chairman WU as the group leader. After meticulous preparation and the unremitting efforts of YIFAN people, we have passed the review of the resumption inspection team of the municipal enterprise prevention and control group. Our production base has met the "six in place" resumption standard, and has resumed work on February 15, 2020.

 

At present, our company has safe stock of raw materials and technicals, and sufficient stock of formulations for domestic market. YIFAN BIOTECHNOLOGY GROUP CO., LTD.  will strive to overcome difficulties to meet the needs of customers at home and abroad, and do its best in service work.

 

In the end, all employees of YIFAN BIOTECHNOLOGY GROUP CO., LTD. express their sincere greetings to customers domestic and abroad. In this particular time, let us go through the storms and overcome difficulties together.

 

Figure 1. The technical production line starts to produce

  

Figure 2. The formulation production line starts to produce

 

Figure 3. Factory resumes shipment

 

 

YIFAN BIOTECHNOLOGY GROUP CO., LTD.

February 21, 2020

 

【返回】